Predictors of adverse outcome among patients with hypertension and coronary artery disease

Journal of the American College of Cardiology

Volumn 47, Issue 3, 2006, Pages 547-551

  Pepine, Carl J ^a   Kowey, Peter R ^b   Kupfer, Stuart ^c   Kolloch, Rainer E ^d   Benetos, Athanase ^e   Mancia, Giuseppe ^f   Coca, Antonio ^g   Cooper Dehoff, Rhonda M ^a   Handberg, Eileen ^a   Gaxiola, Efrain ^h   Sleight, Peter ⁱ   Conti, C Richard ^a   Hewkin, Ann C ^c   Tavazzi, Luigi ^j  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^b LANKENAU HOSPITAL   (United States)

^c ABBOTT LABORATORIES   (United States)

^d UNIVERSITY OF MÜNSTER   (Germany)

^e UNIVERSITÉ DE LORRAINE   (France)

^f UNIVERSITY OF MILANO BICOCCA   (Italy)

^g HOSPITAL CLÍNIC   (Spain)

^h Instituto Cardiovascular de Guadalajara   (Mexico)

ⁱ UNIVERSITY OF OXFORD   (United Kingdom)

^j FONDAZIONE IRCCS POLICLINICO SAN MATTEO   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ATENOLOL; TRANDOLAPRIL PLUS VERAPAMIL; VERAPAMIL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEART FAILURE; HEART INFARCTION; HUMAN; HYPERTENSION; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; REVASCULARIZATION; SMOKING; TRANSIENT ISCHEMIC ATTACK;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; ATENOLOL; BLOOD PRESSURE; CALCIUM CHANNEL BLOCKERS; CEREBROVASCULAR ACCIDENT; CORONARY ARTERIOSCLEROSIS; HUMANS; HYPERTENSION; INDOLES; MIDDLE AGED; MYOCARDIAL INFARCTION; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; VERAPAMIL;

EID: 31644438866     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2005.09.031     Document Type: Article

References (11)

1. American Heart Association Heart Disease and Stroke Statistics - 2005 Update 2005 American Heart Association Dallas, TX
2. B. Williams Recent hypertension trials implications and controversies J Am Coll Cardiol 45; 2005 813 827
3. Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure The sixth report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) Arch Intern Med 157 1997 2413 2446
4. C.J. Pepine, E.M. Handberg, R.M. Cooper-DeHoff A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease: the International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial JAMA 290 2003 2805 2816
5. C.J. Pepine, E. Handberg-Thurmond, R.G. Marks Rationale and design of the International Verapamil SR/Trandolapril Study (INVEST) an Internet-based randomized trial in coronary artery disease patients with hypertension J Am Coll Cardiol 32 1998 1228 1237
6. W.J. Elliott, A.C. Hewkin, S. Kupfer, R. Cooper-DeHoff, C.J. Pepine A drug dose model for predicting clinical outcomes in hypertensive coronary disease patients J Clin Hypertens 7 2005 654 663
7. J.I. Barzilay, R.A. Kronmal, V. Bittner, E. Eaker, E.D. Foster Coronary artery disease in diabetic and nondiabetic patients with lower extremity arterial disease a report from the Coronary Artery Surgery Study Registry Am Heart J 135 1998 1055 1062
8. P. Verdecchia, G. Reboldi, F. Angeli Adverse prognostic significance of new diabetes in treated hypertensive subjects Hypertension 43 2004 963 969
9. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, G. Dagenais The Heart Outcomes Prevention Evaluation Study Investigators Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients N Engl J Med 342 2000 145 153
10. K.M. Fox Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study) Lancet 362 2003 782 788
11. E.E. Calle, M.J. Thun, J.M. Petrelli, C. Rodriguez, C.W. Heath Jr Body-mass index and mortality in a prospective cohort of U.S. adults N Engl J Med 341 1999 1097 1105